Areas of Interest

As of 12/29/18 – See Abbvie Partnerships


Programs focus on investigating both targeted oral therapies and biologics. 

  • Rheumatoid arthritis (RA)
  • Inflammatory bowel disease (IBD)
  • Psoriasis and dermatologic diseases
  • Psoriatic arthritis (PsA)
  • Osteoarthritis (OA)
  • Systemic lupus erythematosis


Both small and large molecule approaches,

  • Solid tumors
  • Hematologic malignancies
  • Next-generation immuno-oncology


Therapies that block neurodegeneration and promote neuroprotection and regeneration, as well as highly validated targets and biomarkers.

  • Alzheimer’s disease
  • Multiple sclerosis
  • Parkinson’s disease


Expansion of antiviral program targeting hepatitis C virus by targeting nonalcoholic steatohepatitis (NASH) and other fibrotic liver diseases.

Additional focus areas

  • Cystic fibrosis
  • New formulations
  • Discovery and development platforms & technologies
Claim Your Page
Is this your organization? Submit your contact information below.